Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome granted inducement awards to ten new employees consisting of options to purchase 120,900 shares and 7,200 RSUs under its 2024 Inducement Plan. The options carry a $20.89 exercise price, matching the October 1, 2026 close, with four-year vesting and a one-year cliff; RSUs vest ratably over four years.
Key figures
- Rsus granted
- 7200
- New employees
- 10
- Vesting years
- 4
- Exercise price
- 20.89
- Options granted
- 120900
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.